Mandi L. Pratt-Chapman, PhD, Attends National LGBTQ Cultural Competency Summit

LGBTQ Cultural Competency Summit 2019 group photo

Mandi L. Pratt-Chapman, PhD, associate center director for patient-centered initiatives and health equity at the George Washington University (GW) Cancer Center, recently attended the second National LGBTQ Cultural Competency Summit in Washington, D.C. The summit took place November 8 and 9 and was hosted by Whitman Walker Health and the National LGBT Cancer Network.

Pratt-Chapman has been an active collaborator with the National LGBT Cancer Network and also participated in the inaugural LGBTQ cultural competency summit in 2018. That summit generated a comprehensive document of proposed Best and Promising Practices for LGBTQ Cultural Competency Trainings. This year's summit was dedicated to revisiting the work of the previous year and incorporating feedback from community reviewers.

According to the National LGBT Cancer Network, no national standards or best practices for LGBTQ cultural competency currently exist. The experts convened for the event will continue developing a white paper and dissemination product to assist trainers in meeting the consensus-based LGBTQI cultural competency standards in the future.

Latest News

Christina Lisi’s personal foundation is built upon community. After receiving a breast cancer diagnosis, she reached out to friends and family, who rallied around her as she sussed out care teams and treatment options. And when she chose GW’s Breast Center and Cancer Center as her cancer journey…
Radiation therapist Badjo Kouadio won the lottery — a few times. The first time was when she entered the Diversity Visa lottery (also known as the Green Card lottery) and came to the United States. The second time was when she became a radiation technologist and began a defining career that…
The GW Cancer Center is proud to announce the addition of Prashanth Ashok Kumar, MD, to its hematologist-oncologist team. Ashok Kumar, who specializes in thoracic cancers and primary CNS tumors, further strengthens the center's commitment to providing top-tier, patient-centered cancer care.